Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -39.559\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) O=C(O)CCC(=O)Nc1nc2ccc([N+](=O)[O-])cc2s1
(b) Cc1cc(C)nc(NC(=S)NC(=O)c2ccccc2F)n1
(c) CCOC(=O)c1c(C)nn(Cc2ccccc2)c1N
(d) Cc1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCN(Cc3ccccc3)CC2)cc1
(e) O=c1cc(CSc2nnc(-c3cccnc3)n2-c2ccccc2F)nc2sccn12
Answer: d. Cc1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCN(Cc3ccccc3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCN(Cc3ccccc3)CC2)cc1
Cc1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCN(Cc3ccccc3)CC2)cc1
N-[2-(4-benzylpiperazin-1-yl)-2-pyridin-3-ylethyl]-4-methylbenzenesulfonamide